Cite
HARVARD Citation
Liu, Y. et al. (2021). Abemaciclib sensitizes HPV‐negative cervical cancer to chemotherapy via specifically suppressing CDK4/6‐Rb‐E2F and mTOR pathways. Fundamental & clinical pharmacology. pp. 156-164. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Liu, Y. et al. (2021). Abemaciclib sensitizes HPV‐negative cervical cancer to chemotherapy via specifically suppressing CDK4/6‐Rb‐E2F and mTOR pathways. Fundamental & clinical pharmacology. pp. 156-164. [Online].